Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 90

1.

Disparities among racial/ethnic groups of patients diagnosed with ependymoma: analyses from the Surveillance, Epidemiology and End Results (SEER) registry.

Stenzel AE, Fenstermaker RA, Wiltsie LM, Moysich KB.

J Neurooncol. 2019 Aug;144(1):43-51. doi: 10.1007/s11060-019-03214-y. Epub 2019 Jun 17.

PMID:
31209774
2.

KX2-361: a novel orally bioavailable small molecule dual Src/tubulin inhibitor that provides long term survival in a murine model of glioblastoma.

Ciesielski MJ, Bu Y, Munich SA, Teegarden P, Smolinski MP, Clements JL, Lau JYN, Hangauer DG, Fenstermaker RA.

J Neurooncol. 2018 Dec;140(3):519-527. doi: 10.1007/s11060-018-2992-4. Epub 2018 Sep 20.

PMID:
30238350
3.

Survivin Monoclonal Antibodies Detect Survivin Cell Surface Expression and Inhibit Tumor Growth In Vivo.

Fenstermaker RA, Figel SA, Qiu J, Barone TA, Dharma SS, Winograd EK, Galbo PM, Wiltsie LM, Ciesielski MJ.

Clin Cancer Res. 2018 Jun 1;24(11):2642-2652. doi: 10.1158/1078-0432.CCR-17-2778. Epub 2018 Mar 14.

4.

Circulating CD9+/GFAP+/survivin+ exosomes in malignant glioma patients following survivin vaccination.

Galbo PM Jr, Ciesielski MJ, Figel S, Maguire O, Qiu J, Wiltsie L, Minderman H, Fenstermaker RA.

Oncotarget. 2017 Oct 10;8(70):114722-114735. doi: 10.18632/oncotarget.21773. eCollection 2017 Dec 29.

5.

NCCN Guidelines Insights: Central Nervous System Cancers, Version 1.2017.

Nabors LB, Portnow J, Ammirati M, Baehring J, Brem H, Butowski N, Fenstermaker RA, Forsyth P, Hattangadi-Gluth J, Holdhoff M, Howard S, Junck L, Kaley T, Kumthekar P, Loeffler JS, Moots PL, Mrugala MM, Nagpal S, Pandey M, Parney I, Peters K, Puduvalli VK, Ragsdale J, Rockhill J, Rogers L, Rusthoven C, Shonka N, Shrieve DC, Sills AK, Swinnen LJ, Tsien C, Weiss S, Wen PY, Willmarth N, Bergman MA, Engh A.

J Natl Compr Canc Netw. 2017 Nov;15(11):1331-1345. doi: 10.6004/jnccn.2017.0166.

PMID:
29118226
6.

Impact of the Number of Metastatic Tumors Treated by Stereotactic Radiosurgery on the Dose to Normal Brain: Implications for Brain Protection.

Rivers C, Tranquilli M, Prasad S, Winograd E, Plunkett RJ, Fenstermaker RA, Fabiano AJ, Podgorsak MB, Prasad D.

Stereotact Funct Neurosurg. 2017;95(5):352-358. doi: 10.1159/000480666. Epub 2017 Oct 11.

7.

Novel vaccines for glioblastoma: clinical update and perspective.

Winograd EK, Ciesielski MJ, Fenstermaker RA.

Immunotherapy. 2016 Nov;8(11):1293-1308. Review.

8.

Clinical study of a survivin long peptide vaccine (SurVaxM) in patients with recurrent malignant glioma.

Fenstermaker RA, Ciesielski MJ, Qiu J, Yang N, Frank CL, Lee KP, Mechtler LR, Belal A, Ahluwalia MS, Hutson AD.

Cancer Immunol Immunother. 2016 Nov;65(11):1339-1352. Epub 2016 Aug 30.

9.

Radiologic response to radiation therapy concurrent with temozolomide for progressive simple dysembryoplastic neuroepithelial tumor.

Morr S, Qiu J, Prasad D, Mechtler LL, Fenstermaker RA.

Acta Neurochir (Wien). 2016 Jul;158(7):1363-6. doi: 10.1007/s00701-016-2832-2. Epub 2016 May 16.

PMID:
27181792
10.

Life-Threatening Mannitol-Induced Hyperkalemia in Neurosurgical Patients.

Fanous AA, Tick RC, Gu EY, Fenstermaker RA.

World Neurosurg. 2016 Jul;91:672.e5-9. doi: 10.1016/j.wneu.2016.04.021. Epub 2016 Apr 13.

PMID:
27086258
11.

Papillary tumor of the pineal region with extended clinical and radiologic follow-up.

Shakir HJ, Qiu J, Prasad D, Mechtler LL, Fenstermaker RA.

Surg Neurol Int. 2015 Oct 7;6(Suppl 18):S451-4. doi: 10.4103/2152-7806.166782. eCollection 2015.

12.

Central Nervous System Cancers, Version 1.2015.

Nabors LB, Portnow J, Ammirati M, Baehring J, Brem H, Brown P, Butowski N, Chamberlain MC, Fenstermaker RA, Friedman A, Gilbert MR, Hattangadi-Gluth J, Holdhoff M, Junck L, Kaley T, Lawson R, Loeffler JS, Lovely MP, Moots PL, Mrugala MM, Newton HB, Parney I, Raizer JJ, Recht L, Shonka N, Shrieve DC, Sills AK Jr, Swinnen LJ, Tran D, Tran N, Vrionis FD, Weiss S, Wen PY, McMillian N, Engh AM.

J Natl Compr Canc Netw. 2015 Oct;13(10):1191-202.

PMID:
26483059
13.

Central nervous system cancers, version 2.2014. Featured updates to the NCCN Guidelines.

Nabors LB, Portnow J, Ammirati M, Brem H, Brown P, Butowski N, Chamberlain MC, DeAngelis LM, Fenstermaker RA, Friedman A, Gilbert MR, Hattangadi-Gluth J, Hesser D, Holdhoff M, Junck L, Lawson R, Loeffler JS, Moots PL, Mrugala MM, Newton HB, Raizer JJ, Recht L, Shonka N, Shrieve DC, Sills AK Jr, Swinnen LJ, Tran D, Tran N, Vrionis FD, Wen PY, McMillian NR, Ho M.

J Natl Compr Canc Netw. 2014 Nov;12(11):1517-23.

14.

Survivin as a potential mediator to support autoreactive cell survival in myasthenia gravis: a human and animal model study.

Kusner LL, Ciesielski MJ, Marx A, Kaminski HJ, Fenstermaker RA.

PLoS One. 2014 Jul 22;9(7):e102231. doi: 10.1371/journal.pone.0102231. eCollection 2014.

15.

Challenges in the development of a survivin vaccine (SurVaxM) for malignant glioma.

Fenstermaker RA, Ciesielski MJ.

Expert Rev Vaccines. 2014 Mar;13(3):377-85. doi: 10.1586/14760584.2014.881255. Review.

PMID:
24521310
16.

Method for securing titanium cerebellar retractors.

Lipinski LJ, Hoppenot RG, Fenstermaker RA, Fabiano AJ.

Surg Neurol Int. 2013 Nov 14;4:146. doi: 10.4103/2152-7806.121404. eCollection 2013.

17.

Central nervous system cancers.

Nabors LB, Ammirati M, Bierman PJ, Brem H, Butowski N, Chamberlain MC, DeAngelis LM, Fenstermaker RA, Friedman A, Gilbert MR, Hesser D, Holdhoff M, Junck L, Lawson R, Loeffler JS, Maor MH, Moots PL, Morrison T, Mrugala MM, Newton HB, Portnow J, Raizer JJ, Recht L, Shrieve DC, Sills AK Jr, Tran D, Tran N, Vrionis FD, Wen PY, McMillian N, Ho M; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2013 Sep 1;11(9):1114-51.

18.

Primary fourth ventricular B-cell lymphoma in an immunocompetent patient.

Fabiano AJ, Syriac S, Fenstermaker RA, Qiu J.

Clin Neuropathol. 2014 Jan-Feb;33(1):94-7. doi: 10.5414/NP300658. No abstract available.

19.

Cranial base repair with combined vascularized nasal septal flap and autologous tissue graft following expanded endonasal endoscopic neurosurgery.

Munich SA, Fenstermaker RA, Fabiano AJ, Rigual NR.

J Neurol Surg A Cent Eur Neurosurg. 2013 Mar;74(2):101-8. doi: 10.1055/s-0032-1330118. Epub 2013 Jan 14. Review.

PMID:
23319331
20.

Tumoral Bing-Neel Syndrome presenting as a cerebellar mass.

Rigual D, Qiu J, Fenstermaker RA, Fabiano AJ.

Clin Neurol Neurosurg. 2013 Jun;115(6):823-6. doi: 10.1016/j.clineuro.2012.07.033. Epub 2012 Aug 16. No abstract available.

21.

Intracranial meningiomas in patients with uterine sarcoma treated with long-term megestrol acetate therapy.

Gruber TJ, Fabiano AJ, Deeb G, Lele SB, Fenstermaker RA.

World Neurosurg. 2011 Nov;76(5):477.e16-20. doi: 10.1016/j.wneu.2011.03.035.

PMID:
22152580
22.

Metastasis suppressor NM23-H1 promotes repair of UV-induced DNA damage and suppresses UV-induced melanomagenesis.

Jarrett SG, Novak M, Dabernat S, Daniel JY, Mellon I, Zhang Q, Harris N, Ciesielski MJ, Fenstermaker RA, Kovacic D, Slominski A, Kaetzel DM.

Cancer Res. 2012 Jan 1;72(1):133-43. doi: 10.1158/0008-5472.CAN-11-1795. Epub 2011 Nov 11.

23.

Central nervous system cancers.

Brem SS, Bierman PJ, Brem H, Butowski N, Chamberlain MC, Chiocca EA, DeAngelis LM, Fenstermaker RA, Friedman A, Gilbert MR, Hesser D, Junck L, Linette GP, Loeffler JS, Maor MH, Michael M, Moots PL, Morrison T, Mrugala M, Nabors LB, Newton HB, Portnow J, Raizer JJ, Recht L, Shrieve DC, Sills AK Jr, Vrionis FD, Wen PY; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2011 Apr;9(4):352-400. No abstract available.

PMID:
21464144
24.

Antitumor cytotoxic T-cell response induced by a survivin peptide mimic.

Ciesielski MJ, Ahluwalia MS, Munich SA, Orton M, Barone T, Chanan-Khan A, Fenstermaker RA.

Cancer Immunol Immunother. 2010 Aug;59(8):1211-21. doi: 10.1007/s00262-010-0845-x. Epub 2010 Apr 27.

25.

Convection enhanced delivery of boronated EGF as a molecular targeting agent for neutron capture therapy of brain tumors.

Yang W, Barth RF, Wu G, Huo T, Tjarks W, Ciesielski M, Fenstermaker RA, Ross BD, Wikstrand CJ, Riley KJ, Binns PJ.

J Neurooncol. 2009 Dec;95(3):355-365. doi: 10.1007/s11060-009-9945-x. Epub 2009 Jul 9.

26.

Endoscopic sellar floor reconstruction with concha bullosa bone autograft and nasal septal flap: technical case report.

Fabiano AJ, Rigual NR, Belber CS, Fenstermaker RA.

Minim Invasive Neurosurg. 2009 Apr;52(2):86-8. doi: 10.1055/s-0028-1104609. Epub 2009 May 18.

PMID:
19452416
27.

Expression of HMP/AN2, a melanoma associated antigen, in murine cerebral gliomas: potential for radioimmunotargeting.

Paul AK, Ciesielski MJ, Sajjad M, Wang X, Ferrone S, Abdel-Nabi H, Fenstermaker RA.

J Neurooncol. 2009 Aug;94(1):21-30. doi: 10.1007/s11060-009-9798-3. Epub 2009 Jan 20.

28.

Immunization with a mimotope of GD2 ganglioside induces CD8+ T cells that recognize cell adhesion molecules on tumor cells.

Wierzbicki A, Gil M, Ciesielski M, Fenstermaker RA, Kaneko Y, Rokita H, Lau JT, Kozbor D.

J Immunol. 2008 Nov 1;181(9):6644-53.

29.

EGFR Intron Recombination in Human Gliomas: Inappropriate Diversion of V(D)J Recombination?

Fenstermaker RA, Ciesielski MJ.

Curr Genomics. 2007 May;8(3):163-70.

30.

Central nervous system cancers.

Brem SS, Bierman PJ, Black P, Brem H, Chamberlain MC, Chiocca EA, DeAngelis LM, Fenstermaker RA, Friedman A, Gilbert MR, Glass J, Grossman SA, Heimberger AB, Junck L, Linette GP, Loeffler JJ, Maor MH, Moots P, Mrugala M, Nabors LB, Newton HB, Olivi A, Portnow J, Prados M, Raizer JJ, Shrieve DC, Sills AK Jr.

J Natl Compr Canc Netw. 2008 May;6(5):456-504. No abstract available.

PMID:
18492461
31.

Therapeutic effect of a T helper cell supported CTL response induced by a survivin peptide vaccine against murine cerebral glioma.

Ciesielski MJ, Kozbor D, Castanaro CA, Barone TA, Fenstermaker RA.

Cancer Immunol Immunother. 2008 Dec;57(12):1827-35. doi: 10.1007/s00262-008-0510-9. Epub 2008 Apr 26.

32.

Subthalamic nucleus metastasis causing hemichorea-hemiballism treated by gamma knife stereotactic radiosurgery.

Karampelas I, Podgorsak MB, Plunkett RJ, Fenstermaker RA.

Acta Neurochir (Wien). 2008 Apr;150(4):395-6; discussion 397. doi: 10.1007/s00701-008-1549-2. Epub 2008 Mar 3. No abstract available.

PMID:
18311526
33.

Molecular targeting and treatment of composite EGFR and EGFRvIII-positive gliomas using boronated monoclonal antibodies.

Yang W, Wu G, Barth RF, Swindall MR, Bandyopadhyaya AK, Tjarks W, Tordoff K, Moeschberger M, Sferra TJ, Binns PJ, Riley KJ, Ciesielski MJ, Fenstermaker RA, Wikstrand CJ.

Clin Cancer Res. 2008 Feb 1;14(3):883-91. doi: 10.1158/1078-0432.CCR-07-1968.

34.

Diagnosis and conservative management of an arteriovenous fistula of the scalp following awake craniotomy for tumor resection.

Karampelas I, Cole PM, Kuensting JM, Fenstermaker RA.

Acta Neurochir (Wien). 2007;149(7):727-8; discussion 728. Epub 2007 May 24. No abstract available.

PMID:
17520167
35.

Molecular targeting and treatment of an epidermal growth factor receptor-positive glioma using boronated cetuximab.

Wu G, Yang W, Barth RF, Kawabata S, Swindall M, Bandyopadhyaya AK, Tjarks W, Khorsandi B, Blue TE, Ferketich AK, Yang M, Christoforidis GA, Sferra TJ, Binns PJ, Riley KJ, Ciesielski MJ, Fenstermaker RA.

Clin Cancer Res. 2007 Feb 15;13(4):1260-8.

36.

Intratumoral hemorrhage after remote subtotal microsurgical resection and gamma knife radiosurgery for vestibular schwannoma.

Karampelas I, Alberico RA, Plunkett RJ, Fenstermaker RA.

Acta Neurochir (Wien). 2007 Mar;149(3):313-6; discussion 316-7. Epub 2007 Feb 2.

PMID:
17273886
37.

Cell-surface receptor for thyroid hormone and tumor cell proliferation.

Davis PJ, Davis FB, Lin HY, Bergh JJ, Mousa S, Hercbergs A, Fenstermaker RA, Ciesielski MJ.

Expert Rev Endocrinol Metab. 2006 Nov;1(6):753-761. doi: 10.1586/17446651.1.6.753.

PMID:
30754150
38.

Acting via a cell surface receptor, thyroid hormone is a growth factor for glioma cells.

Davis FB, Tang HY, Shih A, Keating T, Lansing L, Hercbergs A, Fenstermaker RA, Mousa A, Mousa SA, Davis PJ, Lin HY.

Cancer Res. 2006 Jul 15;66(14):7270-5.

39.

Molecular targeting and treatment of EGFRvIII-positive gliomas using boronated monoclonal antibody L8A4.

Yang W, Barth RF, Wu G, Kawabata S, Sferra TJ, Bandyopadhyaya AK, Tjarks W, Ferketich AK, Moeschberger ML, Binns PJ, Riley KJ, Coderre JA, Ciesielski MJ, Fenstermaker RA, Wikstrand CJ.

Clin Cancer Res. 2006 Jun 15;12(12):3792-802.

40.

Antitumor effects of a xenogeneic survivin bone marrow derived dendritic cell vaccine against murine GL261 gliomas.

Ciesielski MJ, Apfel L, Barone TA, Castro CA, Weiss TC, Fenstermaker RA.

Cancer Immunol Immunother. 2006 Dec;55(12):1491-503. Epub 2006 Feb 17.

PMID:
16485128
41.

Central nervous system cancers: Clinical Practice Guidelines in Oncology.

Brem SS, Bierman PJ, Black P, Blumenthal DT, Brem H, Chamberlain MC, Chiocca EA, DeAngelis LM, Fenstermaker RA, Fine HA, Friedman A, Glass J, Grossman SA, Heimberger AB, Junck L, Levin V, Loeffler JJ, Maor MH, Narayana A, Newton HB, Olivi A, Portnow J, Prados M, Raizer JJ, Rosenfeld SS, Shrieve DC, Sills AK Jr, Spence AM, Vrionis FD; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2005 Sep;3(5):644-90. No abstract available.

PMID:
16194456
42.

Dosimetric accuracy of a staged radiosurgery treatment.

Cernica G, de Boer SF, Diaz A, Fenstermaker RA, Podgorsak MB.

Phys Med Biol. 2005 May 7;50(9):1991-2002. Epub 2005 Apr 13.

PMID:
15843732
43.

Stereotactic gamma knife surgery for trigeminal neuralgia: detailed analysis of treatment response.

Tawk RG, Duffy-Fronckowiak M, Scott BE, Alberico RA, Diaz AZ, Podgorsak MB, Plunkett RJ, Fenstermaker RA.

J Neurosurg. 2005 Mar;102(3):442-9.

PMID:
15796377
44.

Melanotic schwannoma with drop metastases to the caudal spine and high expression of CD117 (c-kit).

Tawk RG, Tan D, Mechtler L, Fenstermaker RA.

J Neurooncol. 2005 Jan;71(2):151-6. Review.

PMID:
15690131
45.

Development of a syngeneic rat brain tumor model expressing EGFRvIII and its use for molecular targeting studies with monoclonal antibody L8A4.

Yang W, Barth RF, Wu G, Ciesielski MJ, Fenstermaker RA, Moffat BA, Ross BD, Wikstrand CJ.

Clin Cancer Res. 2005 Jan 1;11(1):341-50.

46.

Major venous sinus resection in the surgical treatment of recurrent aggressive dural based tumors.

Buster WP, Rodas RA, Fenstermaker RA, Kattner KA.

Surg Neurol. 2004 Dec;62(6):522-9; discussion 529-30.

PMID:
15576120
47.

Cellular antitumor immune response to a branched lysine multiple antigenic peptide containing epitopes of a common tumor-specific antigen in a rat glioma model.

Ciesielski MJ, Kazim AL, Barth RF, Fenstermaker RA.

Cancer Immunol Immunother. 2005 Feb;54(2):107-19. Epub 2004 Aug 31.

PMID:
15340764
48.

2-Methoxyestradiol inhibits proliferation of normal and neoplastic glial cells, and induces cell death, in vitro.

Lis A, Ciesielski MJ, Barone TA, Scott BE, Fenstermaker RA, Plunkett RJ.

Cancer Lett. 2004 Sep 15;213(1):57-65.

PMID:
15312684
49.

Boronated epidermal growth factor as a delivery agent for neutron capture therapy of EGF receptor positive gliomas.

Yang W, Barth RF, Wu G, Bandyopadhyaya AK, Thirumamagal BT, Tjarks W, Binns PJ, Riley K, Patel H, Coderre JA, Ciesielski MJ, Fenstermaker RA.

Appl Radiat Isot. 2004 Nov;61(5):981-5.

PMID:
15308179
50.

Neutron capture therapy of epidermal growth factor (+) gliomas using boronated cetuximab (IMC-C225) as a delivery agent.

Barth RF, Wu G, Yang W, Binns PJ, Riley KJ, Patel H, Coderre JA, Tjarks W, Bandyopadhyaya AK, Thirumamagal BT, Ciesielski MJ, Fenstermaker RA.

Appl Radiat Isot. 2004 Nov;61(5):899-903.

PMID:
15308165

Supplemental Content

Loading ...
Support Center